BIOCHECK UP is an early detection programme for risks and disorders associated with diseases of civilisation. We have structured the content of the Check Up according to profiles, you choose your profile according to your personal preference.

DISCOVER OUR PROFILES 

Our range of profiles has been expanded to include current topics such as nutritional balance/ vegetarianism, intestinal health, daily and sleep patterns and much more. Discover our complete range of profiles on the website: www.biocheckup.ch.

COLOX®

Colorectal cancer screening with a simple blood test.

Patients who have Helsana Primeo supplementary insurance receive a 90% reimbursement of the Colox test.

In Switzerland, 5 people die of colorectal cancer every day, although early detection increases the chances of survival by over 90%!

Colorectal cancer in Switzerland

• Third most common type of cancer
• Second most common cause of cancer deaths
• The risk of this type of cancer increases with age
• The Swiss Cancer League recommends an examination for early detection from the age of 50

Early detection improves the chances of survival

The Colox® test a revolution in colorectal cancer screening

Early detection – an advantage for everyone

Detection of adenomatous polyps and carcinomas at an early stage

Can be prescribed at the same time as other routine examinations

Colox® for the early detection of colorectal cancer

• A simple blood sample is enough
• developed and clinically tested in Switzerland
• A molecular test that measures the reaction of the immune system
• The Colox® test also detects adenomatous polyps as precancerous lesions

Colox® recognizes the tumor-host interaction

Instead of waiting until the tumor releases identifiable markers into the blood, Colox® is based on the very early host response.

3
Differentiation of bone marrow cells at the site of the lesion

A healthy lifestyle and regular screening can help prevent bowel cancer.

Ask your doctor whether Colox® is suitable for you.

How can I be tested with Colox®?

The results will be forwarded to the attending physician, who will then pass them on to you.

IBS-Smart^TM offers a solution that is as simple as it is revolutionary; a simple blood test based on a tube of EDTA blood.

Thanks to IBS-SMART, you no longer have to use a process of elimination to diagnose rds

IBS-Smart is based on the pathophyslology of IBS, which is due to post-infectious molecular changes and at the same time enables a differential diagnosis of IBS to inflammatory bowel diseases.

Pathophyslology of RDS

Studies have shown that there is a direct link between acute gastroenteritis or food poisoning and the occurrence of IBS.

RDS-M OR RDS-D

This results in a form of IBS with a diarrheal component. This manifests itself with abdominal pain, flatulence and diarrhea, among other things.

Symptoms of irritable bowel syndrome are one of the 10 most common reasons why patients consult a doctor

10% of the western population suffer from irritable bowel syndrome1. However, many of the symptoms of IBS also occur in other gastrointestinal diseases:

• Pain and discomfort in the abdominal area, for example, are the two most common reasons for consulting a doctor
• Around 50% of patients suffer from headaches, back pain, sleep disorders and fatigue

The diagnosis of IBS is made more difficult by overlapping symptoms with other diseases.

Until now, IBS-M and IBS-D could only be diagnosed by invasive exclusion diagnostics, which is determined by the Rome III/IV criteria. This led to a lengthy, complex and expensive process.

A simple solution for your complex cases

IBS-SmartTM offers a solution that is as simple as it is revolutionary; a simple blood test based on a tube of EDTA blood.

IBS-Smart is currently the only method that allows you to diagnose and treat IBS quickly and without complex examinations.

Irritable bowel syndrome is divided into three groups:

• IBS-C(onstipation), where constipation predominates;
• RDS-M(ixed), where diarrhea and constipation may alternate;
• RDS-D(iarrhea), where diarrhea is the predominant symptom.

IBS-Smart can be used for RDS-M(ixed) and RDS-D(iarrhea), which account for around 60% of all cases:

IBS-D and IBS-M: intermittent presence of stool types 6/7 – Bristol stool diagram